TL;DR
- The structural problem: Healthtech operators manage clinical data, financial data, health plan contract data, regulatory compliance data, and patient engagement data across 50+ systems — almost none of which are connected to each other or to decisions.
- Visit economics are opaque: Telehealth companies at low volume can see clinician costs at 150–170% of revenue per visit. At scale, that compresses to 45–55%. Most operators don't know which side of that curve they're on until the cash runs out.
- PMPM math is tricky: Health plan contracts priced at $3–$40 PMPM look profitable on paper. The real metric is engaged PMPM — revenue per actively engaged member — which tells you whether your engagement rate is high enough to justify the contract value to the payer.
- Clinical metrics are business metrics: 90-day active engagement rate, time-to-first-outcome, and clinical escalation rate directly drive contract renewal, payer trust, and unit economics — but most healthtech companies track them in clinical dashboards that finance never sees.
- The framework: Healthtech operating intelligence requires five data domains — patient acquisition, visit or session economics, clinical outcomes, health plan contract performance, and regulatory compliance — connected into a single decision layer with metric owners and alert thresholds.
Running a healthtech company is operationally unlike almost any other business. A telehealth platform is simultaneously managing clinical workflows, HIPAA data governance, state-by-state clinician licensure, health plan contract performance, patient acquisition funnels, and software product metrics — often with separate teams, separate tools, and no shared definition of what "performing well" actually means.
The result is a sector that is extraordinarily data-rich and operationally blind. A digital health company can tell you its monthly active users, its net promoter score, and its A1C reduction rate for diabetic patients. It cannot always tell you whether it is making money on each of those patients, whether it will renew its largest health plan contract, or which operational inputs are actually driving clinical and financial outcomes simultaneously.
This framework explains how healthtech operators — from direct-to-consumer telehealth platforms to chronic disease management companies to B2B2C wellness programs — can build operating intelligence across their entire stack: patient acquisition, visit economics, clinical outcome metrics, health plan contract performance, and regulatory data obligations, connected into a decision system that tells operators what is making money, what is leaking margin, and what to do next.
Operating Intelligence for Healthtech. A structured combination of patient acquisition data, visit or session economics, clinical outcome metrics, health plan contract performance data, and regulatory compliance data — connected into a single decision layer that gives healthtech COOs and founders real-time visibility into margin by product line, contract risk by payer, and the specific operational actions that will protect or improve profitability.
Why Healthtech Operations Are Structurally Harder to Manage Than Standard SaaS
Healthtech founders often come to the business with a software background and discover that the operating model does not behave like software. Clinical delivery, regulatory obligations, and payer contracting each add layers of complexity that have no equivalent in a standard SaaS business. Three structural problems define the operating challenge.
Problem 1: Unit Economics Are Not Fixed — They Are Clinician-Dependent
In a software business, the marginal cost of adding another user is near zero once the product is built. In telehealth and clinical digital health, the marginal cost of adding another patient is the cost of clinical time — and clinical time does not scale the way software does.
At low visit volumes, telehealth unit economics are punishing. Clinician compensation as a percentage of revenue per visit can exceed 150% when you account for provider overhead, asynchronous review time, and scheduling inefficiency. A telehealth visit generating $89 in direct-to-consumer revenue may cost $120–$140 to deliver before platform and support costs. That is a negative gross margin at the visit level, masked by subscription revenue or PMPM contract revenue that appears separately in the income statement.
At scale — roughly 10,000 or more monthly encounters — efficient telehealth platforms compress provider cost to 45–55% of revenue per visit, achieving blended gross margins in the 40–55% range. The difference between a money-losing and a profitable telehealth business is often not the price point or the clinical model: it is whether the operator knows which side of the clinician utilization curve they are on, in real time, and has the data systems to manage toward the right side.
Problem 2: Clinical Metrics and Business Metrics Are Reported in Separate Systems
Most healthtech companies build two separate reporting stacks. The clinical team tracks outcome metrics — A1C reduction, blood pressure adherence, depression scale improvement, care plan completion — in clinical dashboards or EMR-adjacent tools. The finance team tracks revenue, churn, customer acquisition cost, and ARPU in financial systems or spreadsheets. The two stacks rarely talk to each other.
The practical consequence is that the clinical team does not know whether their outcomes are profitable to deliver, and the finance team does not know whether the financial model is sustainable because clinical outcomes are driving retention and contract renewal. Healthtech companies that don't bridge these two reporting layers routinely misallocate resources — optimizing for clinical metrics that don't move business outcomes, or cutting costs in ways that destroy clinical performance and, downstream, revenue.
The 90-day active engagement rate is the clearest example. It is a clinical metric — it measures whether enrolled patients are actively using the program — but it is also the leading financial indicator for health plan contract renewal, PMPM performance, and churn. A healthtech company tracking engagement only in clinical dashboards is making a strategic error. Engagement is a revenue metric. It belongs on the operating dashboard alongside ARR and gross margin.
Problem 3: Regulatory Data Obligations Are Operational Obligations in Disguise
HIPAA, FDA SaMD requirements, state telehealth licensure rules, and health plan audit obligations are typically treated as legal and compliance problems. In practice, they are operational data problems. Each regulatory framework generates data that must be captured, maintained, and surfaced — and failure to maintain that data in the correct format, at the correct granularity, creates operational risk that can materially affect business continuity.
Healthcare technology stacks average more than 50 systems, and integrating them costs $50,000–$300,000 per integration. Most healthtech operators have not integrated their compliance data flows with their operational data flows. That means HIPAA audit logs, FDA software documentation, and state licensure expiration dates are sitting in separate systems, tracked manually, and invisible to the operating layer until a violation or expiration forces a crisis response.
The Healthtech Metrics Framework: Five Data Domains
Healthtech operating intelligence is not a single dashboard. It is the integration of five data domains that each answer a different operating question. The value comes from connecting them, not from optimizing any one in isolation.
Domain 1: Patient Acquisition Economics
Patient acquisition cost (PAC) is the total cost — paid search, content, referral fees, sales commissions, onboarding support — required to convert a prospect into an active patient or enrolled member. In digital health, PAC varies dramatically by channel and condition:
- Paid search (Google Ads): $100–$600 for most conditions; $800–$2,500 for behavioral health
- Paid social (Meta, TikTok): $50–$200 at scale for wellness and chronic disease programs
- Referral and partnership channels: $25–$100 for incentivized referral; near-zero for organic physician referral
- B2B2C (employer/health plan): Sales cycle CAC of $10,000–$80,000 per contract, amortized across eligible members
The benchmark that matters is not PAC in isolation. It is the LPV-to-PAC ratio — lifetime patient value divided by patient acquisition cost. For a sustainable digital health business, LPV:PAC should be at least 3:1, with a payback period under 18 months for direct-to-consumer models and under 24 months for B2B2C. Companies that cannot calculate this ratio have a data infrastructure problem before they have a growth problem.
The operating intelligence requirement: PAC must be tracked by channel, by condition or product line, and — critically — in relation to the 90-day retention rate of patients acquired through each channel. A channel with a $150 PAC and 30% 90-day retention is worse than a channel with a $300 PAC and 70% 90-day retention. Without connecting acquisition data to retention data, you are optimizing for the wrong number.
Domain 2: Visit and Session Economics
Visit economics measure whether the clinical delivery layer of the business is profitable at the unit level. The key metrics and benchmarks:
- Revenue per visit: Direct-to-consumer telehealth visits price at $40–$120 depending on condition complexity; $89 is a common benchmark for general acute care synchronous visits
- Cost per visit (COGS): Provider time ($25–$45), platform and infrastructure ($8–$15), support and care coordination ($8–$12) — total COGS of $41–$72 per visit at efficient scale
- Gross margin per visit: Efficient telehealth platforms target 40–55% gross margin on visit revenue at 10,000+ monthly encounters; below 30% indicates a clinician utilization or scheduling problem
- Clinician utilization rate: The percentage of scheduled clinician hours that generate billable encounters; benchmark for efficient operations is 70–80%; below 60% means you are paying for clinical capacity that isn't being used
- No-show and cancellation rate: Industry average 15–25%; top performers operate below 10% through active reminder and rescheduling workflows
For subscription-based digital health models, visit economics interact with subscription revenue in ways that can obscure the true unit margin. A company charging $79/month for a chronic disease management subscription may deliver 1.5 telehealth visits per member per month. If those visits cost $60 each to deliver, the visit COGS alone ($90) exceeds the subscription revenue ($79) — leaving negative margin before accounting for platform costs, support, or acquisition costs. This dynamic is common and underappreciated. Operating intelligence requires that subscription and visit economics be tracked jointly, not separately.
Domain 3: Clinical Outcome Metrics as Operating KPIs
Clinical outcomes are not just patient health metrics. In a healthtech business, clinical outcome performance directly drives contract renewal probability, payer trust, patient retention, and the ability to move up the value-based care contracting ladder. The five clinical metrics that belong on the operating dashboard:
- 90-day active engagement rate: The percentage of enrolled patients who have at least one meaningful interaction with the program in the last 90 days. Benchmark: 50–65% for well-run chronic disease programs; below 40% puts health plan contracts at risk of non-renewal.
- Time-to-first-outcome: The average number of days between enrollment and first measurable clinical improvement. A shorter time-to-first-outcome drives retention by confirming value to the patient early; benchmark varies by condition but 30–45 days is a meaningful target for most programs.
- Condition-specific outcome improvement rate: The percentage of enrolled patients achieving the primary clinical endpoint (A1C reduction ≥ 0.5%, blood pressure normalization, PHQ-9 score improvement ≥ 5 points, etc.). This is the metric payers cite in contract renewal conversations.
- Clinical escalation rate: The percentage of patients requiring escalation to a higher level of care (ED visit, specialist referral, inpatient admission). High escalation rates indicate the program is not capturing patients early enough or managing acuity effectively — and they directly increase payer medical loss ratio, which threatens the contract.
- Care plan completion rate: The percentage of patients completing assigned care tasks, medication adherence milestones, or program modules within the defined window. A leading indicator of outcome achievement and 90-day engagement.
Domain 4: Health Plan and PMPM Contract Performance
Many digital health companies eventually transition from direct-to-consumer or employer-direct models to health plan partnerships. PMPM contracts are the standard vehicle: the payer pays a fixed monthly fee per eligible member, regardless of whether that member actively uses the service. The economics are predictable — and the risks are structural.
PMPM rates vary significantly by product complexity: wellness navigation programs price at $3–$8 PMPM; chronic disease management programs at $15–$40 PMPM; complex care coordination for high-acuity populations at $50–$100 PMPM or more. The revenue is stable. The operating risk is that contracted engagement expectations — the minimum engagement rate the payer expects in exchange for the PMPM fee — create a performance floor that the company must meet or face contract renegotiation.
The operating metrics that matter for PMPM contract management:
- Engaged PMPM: Total contract revenue divided by number of actively engaged members (not total eligible members). This tells you the effective revenue per patient who is actually receiving value — and whether the contract is economically sustainable relative to delivery cost.
- Eligibility file match rate: The percentage of health plan member eligibility files that successfully match to enrolled patients. Low match rates indicate integration problems that inflate apparent eligible member counts and deflate engagement rates.
- Contract utilization rate: Actively engaged members as a percentage of total contracted eligible members. Benchmark: 15–30% for general population programs; 40–60% for condition-specific programs with active outreach.
- Renewal risk score: A composite metric tracking engagement rate trends, outcome performance relative to contract thresholds, and open escalations or audit items for each payer relationship. This is a forward-looking indicator that most healthtech companies build manually in spreadsheets — and should be an automated dashboard metric.
Domain 5: Regulatory and Compliance Data as Operational Inputs
Regulatory compliance in healthtech is not a one-time certification. It is a continuous operational data obligation that must be tracked, monitored, and surfaced alongside financial and clinical metrics.
Regulatory Data Obligations: What Healthtech Operators Must Track
Healthtech regulatory obligations cluster into three distinct frameworks, each generating its own data obligations.
HIPAA: Continuous Monitoring, Not One-Time Compliance
HIPAA applies to any healthtech company handling Protected Health Information — which includes health records, visit notes, lab results, billing information, and any data that could identify an individual in relation to their health status. For most telehealth and digital health companies, that means virtually all patient-facing data.
HIPAA's operating intelligence implication is often misunderstood. The regulation does not just require a one-time risk assessment and a set of policies. It requires continuous monitoring of data flows, real-time breach detection capability, and documented evidence of compliance that can be produced during a HHS Office for Civil Rights audit. Companies that treat HIPAA as a checkbox completed at founding — rather than an ongoing operational data function — are typically unprepared when an incident occurs.
The operational metrics to track: PHI access log volume by system (a sudden spike can indicate unauthorized access), breach incident count with days-open status, training completion rate by department, and Business Associate Agreement (BAA) coverage — the percentage of vendors with PHI access who have a current, signed BAA on file. Incomplete BAA coverage is one of the most common HIPAA compliance gaps and one of the most actionable to close.
FDA SaMD: Data Obligations for Clinical Software Products
Software as a Medical Device (SaMD) is any software that performs medical purposes without being part of a hardware device. Under the FDA's framework, SaMD is classified into Class I, II, or III based on the risk of the intended use and the condition it targets. Most digital diagnostics, AI-driven clinical decision support, and remote patient monitoring software falls into SaMD classification.
The data obligations for FDA-cleared SaMD are substantial and ongoing. FDA 21 CFR Part 820 requires documented design controls — software requirements specifications, verification testing records, and validation evidence that the software performs as intended in real-world use. Since October 2023, FDA submissions for SaMD must include a Software Bill of Materials (SBOM) identifying every commercial, open-source, and off-the-shelf component with version information. Cybersecurity threat modeling and post-market patching procedures are also mandatory.
The operating intelligence implication: SaMD companies must maintain a living documentation set that is updated with every software release. This is not a legal team function — it is a product and engineering function with compliance implications. Tracking SBOM currency, open cybersecurity vulnerabilities by severity, and software validation test coverage as operational KPIs keeps the compliance documentation layer current and reduces FDA audit risk.
State Telehealth Licensure: The Hidden Operating Data Problem
Telehealth companies operating across state lines must ensure that every clinician providing care is licensed in the state where the patient is located at the time of the visit. Clinician licensure is time-limited — most state medical licenses must be renewed every 1–2 years — and each state has different application timelines, fee structures, and continuing education requirements.
At scale, a telehealth company with 200 clinicians providing care across 40 states may be managing 800+ active license records simultaneously. The operational failure mode is not intentional non-compliance — it is administrative oversight. A clinician license that expires without triggering a renewal workflow means that clinician is providing unlicensed care, creating malpractice exposure and potentially triggering state medical board enforcement.
The operating metric: clinician licensure coverage by state, tracked as the percentage of active clinicians with a current, non-expired license for each state they are credentialed to serve, with automated 90-day and 30-day renewal alerts. This metric belongs on the COO's operating dashboard, not buried in an HR system.
Healthtech Operating Intelligence: Benchmarks at a Glance
| Metric | Benchmark | Warning Threshold |
|---|---|---|
| Patient acquisition cost (paid search) | $100–$600 | >$800 without proportional LPV |
| LPV-to-PAC ratio | 3:1 or higher | Below 2:1 |
| Clinician utilization rate | 70–80% | Below 60% |
| Gross margin per visit (at scale) | 40–55% | Below 30% |
| 90-day active engagement rate | 50–65% | Below 40% |
| No-show / cancellation rate | Below 10% | Above 20% |
| PMPM contract utilization rate | 15–30% (general); 40–60% (condition-specific) | Below contracted minimums |
| BAA coverage (HIPAA) | 100% of PHI-handling vendors | Any gap |
| Clinician licensure coverage | 100% current by state served | Any expired license |
Building the Operating Intelligence Layer: Where to Start
Most healthtech operators attempting to build operating intelligence for the first time face the same prioritization problem: the data is distributed across too many systems and no single team owns the integration. The practical starting sequence:
Step 1: Map the Data Sources Against the Five Domains
Before building anything, document which systems are the authoritative source for each of the five domains. Patient acquisition data typically lives in a combination of CRM, marketing analytics, and product analytics tools. Visit economics live in EMR or scheduling systems and billing platforms. Clinical outcomes may be in a proprietary platform, an EMR, or a combination. Health plan contract performance is often only available through payer portals with no API access. Regulatory compliance data is frequently manual.
The mapping exercise typically surfaces three to five critical integration gaps that are generating blind spots in operating performance. Those gaps — not a comprehensive data warehouse — are the first thing to close.
Step 2: Define the Eight Metrics That Require Weekly Attention
Not every metric in the framework requires weekly review. The eight metrics that genuinely require the COO's attention every week are: 90-day active engagement rate (by product and payer), clinician utilization rate, cost per visit versus revenue per visit, PAC by top three acquisition channels, PMPM contract utilization against minimums for any contract in its renewal window, open compliance incidents with days-open count, clinician licensure expirations in the next 90 days, and care plan completion rate as a leading indicator of outcomes.
These eight metrics are not a comprehensive operating view. They are the early warning system — the signals that, if deteriorating, require action before they become contract, margin, or regulatory crises.
Step 3: Connect Clinical and Financial Data Before Connecting Everything Else
The highest-value integration in a healthtech operating stack is the connection between clinical outcome data and financial data. When 90-day engagement rate can be compared against PMPM contract performance, and when clinical escalation rate can be compared against blended gross margin, the operating team can see whether clinical investments are generating financial return — and whether financial pressures are creating clinical quality risks.
That integration is not a data science project. It requires agreeing on a shared patient or member identifier across the clinical and financial systems, a shared reporting cadence, and a shared set of metric definitions that both teams accept. The technical work is secondary to the organizational alignment.